Glaukos Corp (GKOS)
108.52
+3.50
(+3.34%)
USD |
NYSE |
May 07, 15:10
Glaukos Revenue (TTM): 326.43M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 326.43M |
December 31, 2023 | 314.71M |
September 30, 2023 | 303.57M |
June 30, 2023 | 296.79M |
March 31, 2023 | 289.08M |
December 31, 2022 | 282.86M |
September 30, 2022 | 284.88M |
June 30, 2022 | 288.32M |
March 31, 2022 | 293.72M |
December 31, 2021 | 294.01M |
September 30, 2021 | 294.00M |
June 30, 2021 | 284.13M |
March 31, 2021 | 237.59M |
December 31, 2020 | 224.96M |
September 30, 2020 | 217.57M |
June 30, 2020 | 211.25M |
March 31, 2020 | 238.29M |
December 31, 2019 | 236.98M |
September 30, 2019 | 225.21M |
Date | Value |
---|---|
June 30, 2019 | 210.61M |
March 31, 2019 | 195.17M |
December 31, 2018 | 181.28M |
September 30, 2018 | 168.85M |
June 30, 2018 | 165.36M |
March 31, 2018 | 163.48M |
December 31, 2017 | 159.25M |
September 30, 2017 | 150.78M |
June 30, 2017 | 139.94M |
March 31, 2017 | 127.21M |
December 31, 2016 | 114.40M |
September 30, 2016 | 101.50M |
June 30, 2016 | 90.93M |
March 31, 2016 | 80.13M |
December 31, 2015 | 71.70M |
September 30, 2015 | 65.54M |
June 30, 2015 | 58.66M |
March 31, 2015 | 52.00M |
December 31, 2014 | 45.59M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
210.61M
Minimum
Jun 2019
326.43M
Maximum
Mar 2024
267.75M
Average
284.50M
Median
Revenue (TTM) Benchmarks
Boston Scientific Corp | 14.71B |
Globus Medical Inc | 1.568B |
PROCEPT BioRobotics Corp | 156.33M |
Accuray Inc | 430.55M |
Asensus Surgical Inc | 8.577M |